Coronary Stents Market (2026 - 2035)

ID: MRFR/MED/5473-HCR
130 Pages
Vikita Thakur
Last Updated: July 10, 2026
Coronary Stents Market Research Report By Product Type (Drug-Eluting Stents, Bare Metal Stents, Bioresorbable Vascular Scaffolds), By Material (Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Polymer), By End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), By Deployment (Balloon-Expandable Stents, Self-Expandable Stents) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Industry Forecast to 2035.
Coronary Stents Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)4.8%
2025 Market SizeUSD 8.92 Billion
2035 Market SizeUSD 14.26 Billion
Key Players
Abbott Laboratories
Boston Scientific
Medtronic
Terumo Corporation
B. Braun Melsungen
MicroPort Scientific
Opportunities
  • Bioresorbable Scaffold Commercialization
  • Emerging-Market Infrastructure Build-Out
  • Digital Twin and Predictive Analytics Platforms
  1. 1 Market Overview |
    1. 1.1 Study Assumptions & Market Definition |
    2. 1.2 Scope of the Study |
    3. 1.3 Research Methodology
  2. 2 Market Summary & Key Takeaways
  3. 3 Market Dynamics |
    1. 3.1 Market Drivers Analysis | |
      1. 3.1.1 Rising CAD Prevalence in Aging Populations | |
      2. 3.1.2 AI-Guided Intravascular Imaging Adoption | |
      3. 3.1.3 Volume-Based Procurement Reforms in Asia | |
      4. 3.1.4 Ultrathin Strut Platform Clinical Superiority | |
      5. 3.1.5 Ambulatory Surgical Center Expansion |
    2. 3.2 Market Restraints Analysis | |
      1. 3.2.1 Cobalt-Chromium Alloy Supply Constraints | |
      2. 3.2.2 Regulatory Approval Timelines for Novel Scaffolds | |
      3. 3.2.3 Generic Stent Commoditization & Price Erosion | |
      4. 3.2.4 Long-Term Safety Data Gaps for Bioresorbable Platforms | |
      5. 3.2.5 Rising Adoption of Drug-Coated Balloons as Alternatives |
    3. 3.3 Market Opportunity Analysis | |
      1. 3.3.1 Bioresorbable Scaffold Commercialization | |
      2. 3.3.2 Emerging-Market Infrastructure Build-Out | |
      3. 3.3.3 Digital Twin and Predictive Analytics Platforms | |
      4. 3.3.4 Hybrid Revascularization Strategies | |
      5. 3.3.5 Data Monetization Through Registry Analytics |
    4. 3.4 Industry Value Chain Analysis |
    5. 3.5 Porter's Five Forces Analysis
  4. 4 Global Coronary Stents Market Size & Forecast (2021–2035) |
    1. 4.1 Historical Market Size (2021–2025) |
    2. 4.2 Current & Forecast Market Size (2026–2035) |
    3. 4.3 Market Size by Revenue (USD Billion) |
    4. 4.4 Year-over-Year Growth Analysis
  5. 5 Segmentation Analysis |
    1. 5.1 By Product Type | |
      1. 5.1.1 Drug-Eluting Stent | |
      2. 5.1.2 Bare-Metal Coronary Stent | |
      3. 5.1.3 Bioabsorbable Vascular Scaffold |
    2. 5.2 By Biomaterial | |
      1. 5.2.1 Metallic | |
      2. 5.2.2 Polymeric |
    3. 5.3 By Mode of Delivery | |
      1. 5.3.1 Balloon-Expandable Stent | |
      2. 5.3.2 Self-Expanding Stent |
    4. 5.4 By End User | |
      1. 5.4.1 Hospitals | |
      2. 5.4.2 Ambulatory Surgical Centers
  6. 6 Regional Analysis |
    1. 6.1 North America | |
      1. 6.1.1 United States | |
      2. 6.1.2 Canada | |
      3. 6.1.3 Mexico |
    2. 6.2 Europe | |
      1. 6.2.1 Germany | |
      2. 6.2.2 United Kingdom | |
      3. 6.2.3 France | |
      4. 6.2.4 Italy | |
      5. 6.2.5 Spain | |
      6. 6.2.6 Nordic Countries | |
      7. 6.2.7 Russia | |
      8. 6.2.8 Rest of Europe |
    3. 6.3 Asia-Pacific | |
      1. 6.3.1 China | |
      2. 6.3.2 India | |
      3. 6.3.3 Japan | |
      4. 6.3.4 South Korea | |
      5. 6.3.5 ASEAN | |
      6. 6.3.6 Rest of Asia-Pacific |
    4. 6.4 South America | |
      1. 6.4.1 Brazil | |
      2. 6.4.2 Argentina | |
      3. 6.4.3 Rest of South America |
    5. 6.5 Middle East & Africa | |
      1. 6.5.1 Saudi Arabia | |
      2. 6.5.2 UAE | |
      3. 6.5.3 South Africa | |
      4. 6.5.4 Egypt | |
      5. 6.5.5 Rest of MEA
  7. 7 Competitive Landscape |
    1. 7.1 Market Share Analysis (2025) |
    2. 7.2 Competitive Benchmarking Matrix |
    3. 7.3 Company Profiles | |
      1. 7.3.1 Abbott Laboratories | |
      2. 7.3.2 Boston Scientific Corporation | |
      3. 7.3.3 Medtronic plc | |
      4. 7.3.4 Terumo Corporation | |
      5. 7.3.5 B. Braun Melsungen | |
      6. 7.3.6 MicroPort Scientific Corporation | |
      7. 7.3.7 Biotronik SE & Co. KG | |
      8. 7.3.8 Lepu Medical Technology | |
      9. 7.3.9 Cook Medical | |
      10. 7.3.10 Cardinal Health
  8. 8 Future Outlook & Strategic Recommendations (2026–2035) |
    1. 8.1 AI-Integrated Catheterization Labs |
    2. 8.2 Bioresorbable Platform Evolution |
    3. 8.3 Precision Medicine and Pharmacogenomics |
    4. 8.4 ESG and Supply-Chain Sustainability
  9. 9 Recent Developments & News
  10. 10 Frequently Asked Questions (FAQs)
  11. 11 Report Scope & Methodology |
    1. 11.1 Study Period & Base Year |
    2. 11.2 Data Sources & Citations |
    3. 11.3 Abbreviations
  12. 12 LIST OF TABLES |
  13. TABLE 1 Global Coronary Stents Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
  14. TABLE 2 Global Coronary Stents Market — Year-over-Year Growth Analysis, 2021–2035 |
  15. TABLE 3 Driver Impact Analysis — Coronary Stents Market |
  16. TABLE 4 Restraint Impact Analysis — Coronary Stents Market |
  17. TABLE 5 Regional Market Share Summary — Coronary Stents Market, 2025 |
  18. TABLE 6 North America Coronary Stents Market, by Country, 2021–2035 (USD Billion) |
  19. TABLE 7 Europe Coronary Stents Market, by Country, 2021–2035 (USD Billion) |
  20. TABLE 8 Asia-Pacific Coronary Stents Market, by Country, 2021–2035 (USD Billion) |
  21. TABLE 9 South America Coronary Stents Market, by Country, 2021–2035 (USD Billion) |
  22. TABLE 10 Middle East & Africa Coronary Stents Market, by Country, 2021–2035 (USD Billion) |
  23. TABLE 11 Global Coronary Stents Market Size, by Product Type, 2021–2035 (USD Billion) |
  24. TABLE 12 Global Coronary Stents Market Size, by Biomaterial, 2021–2035 (USD Billion) |
  25. TABLE 13 Global Coronary Stents Market Size, by Mode of Delivery, 2021–2035 (USD Billion) |
  26. TABLE 14 Global Coronary Stents Market Size, by End User, 2021–2035 (USD Billion) |
  27. TABLE 15 Competitive Benchmarking Matrix — Global Coronary Stents Market, 2025 |
  28. TABLE 16 Company Profiles — Key Players, Global Coronary Stents Market |
  29. TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
  30. TABLE 18 North America Coronary Stents Market Size, by Product Type, 2021–2035 (USD Billion) |
  31. TABLE 19 North America Coronary Stents Market Size, by Biomaterial, 2021–2035 (USD Billion) |
  32. TABLE 20 North America Coronary Stents Market Size, by Mode of Delivery, 2021–2035 (USD Billion) |
  33. TABLE 21 North America Coronary Stents Market Size, by End User, 2021–2035 (USD Billion) |
  34. TABLE 22 Europe Coronary Stents Market Size, by Product Type, 2021–2035 (USD Billion) |
  35. TABLE 23 Europe Coronary Stents Market Size, by Biomaterial, 2021–2035 (USD Billion) |
  36. TABLE 24 Europe Coronary Stents Market Size, by Mode of Delivery, 2021–2035 (USD Billion) |
  37. TABLE 25 Europe Coronary Stents Market Size, by End User, 2021–2035 (USD Billion) |
  38. TABLE 26 Asia-Pacific Coronary Stents Market Size, by Product Type, 2021–2035 (USD Billion) |
  39. TABLE 27 Asia-Pacific Coronary Stents Market Size, by Biomaterial, 2021–2035 (USD Billion) |
  40. TABLE 28 Asia-Pacific Coronary Stents Market Size, by Mode of Delivery, 2021–2035 (USD Billion) |
  41. TABLE 29 Asia-Pacific Coronary Stents Market Size, by End User, 2021–2035 (USD Billion) |
  42. TABLE 30 South America Coronary Stents Market Size, by Product Type, 2021–2035 (USD Billion) |
  43. TABLE 31 South America Coronary Stents Market Size, by Biomaterial, 2021–2035 (USD Billion) |
  44. TABLE 32 South America Coronary Stents Market Size, by Mode of Delivery, 2021–2035 (USD Billion) |
  45. TABLE 33 South America Coronary Stents Market Size, by End User, 2021–2035 (USD Billion) |
  46. TABLE 34 Middle East & Africa Coronary Stents Market Size, by Product Type, 2021–2035 (USD Billion) |
  47. TABLE 35 Middle East & Africa Coronary Stents Market Size, by Biomaterial, 2021–2035 (USD Billion) |
  48. TABLE 36 Middle East & Africa Coronary Stents Market Size, by Mode of Delivery, 2021–2035 (USD Billion) |
  49. TABLE 37 Middle East & Africa Coronary Stents Market Size, by End User, 2021–2035 (USD Billion) |
  50. TABLE 38 Report Scope & Methodology — Coronary Stents Market |
  51. TABLE 39 Detailed Sources and Citations
  52. 13 LIST OF FIGURES |
  53. FIGURE 1 Coronary Stents Market Dynamics — Drivers, Restraints, Opportunities |
  54. FIGURE 2 Value Chain Analysis — Global Coronary Stents Market |
  55. FIGURE 3 Porter's Five Forces Analysis — Coronary Stents Market |
  56. FIGURE 4 Global Coronary Stents Market Size Trend, 2021–2035 (USD Billion) |
  57. FIGURE 5 Coronary Stents Market Share, by Product Type, 2025 |
  58. FIGURE 6 Coronary Stents Market Share, by Biomaterial, 2025 |
  59. FIGURE 7 Coronary Stents Market Share, by Mode of Delivery, 2025 |
  60. FIGURE 8 Coronary Stents Market Share, by End User, 2025 |
  61. FIGURE 9 Coronary Stents Market Revenue Share, by Region, 2025 |
  62. FIGURE 10 North America Coronary Stents Market Size, by Country, 2021–2035 |
  63. FIGURE 11 Europe Coronary Stents Market Size, by Country, 2021–2035 |
  64. FIGURE 12 Asia-Pacific Coronary Stents Market Size, by Country, 2021–2035 |
  65. FIGURE 13 South America Coronary Stents Market Size, by Country, 2021–2035 |
  66. FIGURE 14 Middle East & Africa Coronary Stents Market Size, by Country, 2021–2035 |
  67. FIGURE 15 Competitive Landscape — Market Share Analysis, 2025

Segmentation Quick Reference

DimensionSub-SegmentsDominant SegmentFastest Growing Segment
Product TypeDrug-Eluting Stent, Bare-Metal Coronary Stent, Bioabsorbable Vascular ScaffoldDrug-Eluting StentBioabsorbable Vascular Scaffold
BiomaterialMetallic, PolymericMetallicPolymeric
Mode of DeliveryBalloon-Expandable Stent, Self-Expanding StentBalloon-Expandable StentSelf-Expanding Stent
End UserHospitals, Ambulatory Surgical CentersHospitalsAmbulatory Surgical Centers
RegionNorth America, Europe, Asia-Pacific, South America, Middle East & AfricaNorth AmericaAsia-Pacific

 

 

Market Segmentation Overview

By Product Type

Sub-SegmentKey Trend
Drug-Eluting StentShift toward bioabsorbable-polymer and polymer-free coatings enabling shorter antiplatelet therapy
Bare-Metal Coronary StentSustained demand in price-regulated and VBP procurement environments
Bioabsorbable Vascular ScaffoldSecond- and third-generation designs addressing scaffold thrombosis and late recoil

 

Drug-Eluting Stents continue to dominate product-type segmentation as iterative design improvements in strut thickness, polymer chemistry, and drug-release kinetics extend clinical durability. Bioabsorbable Vascular Scaffolds are attracting renewed clinical interest as next-generation designs enter pivotal trials with improved mechanical and resorption profiles.

By Biomaterial

Sub-SegmentKey Trend
MetallicUltra-thin cobalt-chromium and platinum-chromium alloys with sub-65 µm strut profiles
PolymericMagnesium- and PLLA-based platforms with accelerated resorption timelines

 

Metallic biomaterials remain foundational to the Coronary Stents Market, with alloy innovation focused on maximizing radial strength while minimizing strut thickness. Polymeric alternatives are gaining traction as improved processing techniques produce more consistent degradation kinetics.

By Mode of Delivery

Sub-SegmentKey Trend
Balloon-Expandable StentEnhanced delivery catheter trackability and lower crossing profiles
Self-Expanding StentGrowing adoption for aorto-ostial and bifurcation lesion treatment

 

Balloon-Expandable Stents benefit from operator familiarity and precise sizing control. Self-Expanding Stents are expanding into complex anatomical subsets where conformability and gradual radial force application offer clinical advantages.

By End User

Sub-SegmentKey Trend
HospitalsCentralized complex PCI capability with hybrid OR integration
Ambulatory Surgical CentersReimbursement parity driving elective case migration to outpatient settings

 

Hospitals handle the majority of acute and complex procedures, while ASCs are absorbing an increasing share of elective stenting volume as payer policies evolve to support outpatient interventional cardiology.

 

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.